Dehydroepiandrosterone (DHEA) attenuates cocaine-seeking behavior in the self-administration model in rats

European Neuropsychopharmacology

Volumn 16, Issue 5, 2006, Pages 329-339

  Maayan, Rachel ^a   Lotan, Sharon ^a   Doron, Ravid ^b   Shabat Simon, Maytal ^b   Gispan Herman, Iris ^b   Weizman, Abraham ^a,c   Yadid, Gal ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Cocaine; Cocaine seeking behavior; Dehydroepiandrosterone (DHEA); Neurosteroids; Self administration

Indexed keywords

COCAINE; DOPAMINE; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN PROTECTION; BRAIN REGION; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG DEPENDENCE TREATMENT; DRUG SELF ADMINISTRATION; MALE; MOOD; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; SEROTONIN BRAIN LEVEL; WITHDRAWAL SYNDROME;

AFFECT; ANIMALS; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NERVE TISSUE PROTEINS; PREGNENOLONE; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SELF ADMINISTRATION; SEROTONIN;

EID: 33744540563     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2005.10.002     Document Type: Article

References (57)

1. Baker D.A., McFarland K., Lake R.W., Shen H., Tang X.C., Toda S., and Kalivas P.W. Neuroadaptation in cysteine-glutamate exchange underline cocaine relapse. Neuroscience 6 (2003) 743-749
2. Baulieu E.E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23 (1998) 963-987
3. Buydens-Branchey L., and Branchey M. Association between low plasma levels of cholesterol and relapse in cocaine addicts. Psychosom. Med. 65 (2003) 86-91
4. Buydens-Branchey L., Branchey M., Hudson J., and Majewska M.D. Perturbations of plasma cortisol and DHEAS following discontinuation of cocaine use in cocaine addicts. Psychoneuroendocrinology 27 (2002) 83-97
5. Chao J., and Nestler E.J. Molecular neurobiology of drug addiction. Annu. Res. Med. 55 (2004) 113-132
6. DiChiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 375 (1999) 13-30
7. Dubrovsky B.O. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 29 (2005) 169-192
8. Goeders N.E. A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22 (1997) 237-259
9. Goeders N.E. The HPA axis and cocaine reinforcement. Psychoneuroendocrinology 27 (2002) 13-33
10. Hayashi T., and Su T.P. Intracellular dynamics of sigma-1 receptors (sigma (1) binding sites) in NG108-15 cells. J. Pharmacol. Exp. Ther. 306 (2003) 726-733
11. Hayashi T., and Su T.P. Sigma-1 receptor ligands: potential in treatment of neuropsychiatric disorders. CNS Drugs 18 (2004) 269-284
12. Jackson A., Mead A.N., Rocha B.A., and Stephens D.N. AMPA receptors and motivation for drug: effect of selective antagonist NBQX on behavioral sensitization and on self-administration in mice. Behav. Pharmacol. 9 (1998) 457-467
13. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., and Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. PNAS 95 (1998.) 1852-1857
14. Kaminski R.M., Gasior H., Carter R.B., and Witkin J.M. Protective efficacy of neuroactive steroids against cocaine kindles-seizures in mice. Eur. J. Pharmacol. 474 (2003) 217-222
15. Koob G.F. The role for GABA mechanisms in the motivational effect of alcohol. Biochem. Pharmacol. 68 (2004) 1515-1525
16. Leshner A.I. Addiction is a brain disease, and it matters. Science 278 (1997) 45-47
17. Levy A.D., Li Q., Kerr J.E., Rittenhouse P.A., Milonas G., Cabrera T.M., Battaglia G., Alvarez-Sanz M.C., and Van de Kar L.D. Cocaine-induced elevation of plasma adrenocorticotropin hormone and corticosterone is mediated by serotonergic neurons. J. Pharmacol. Exp. Ther. 259 (1991) 495-500
18. Maayan R., Morad O., Dorfman P., Overstreet D.H., Weizman A., and Yadid G. The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shock in an animal model of depression. Eur. Neuropsychopharmacol. 15 (2005) 253-262
19. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38 (1992) 379-395
20. Majewska M.D. Neuronal actions of dehydropiandrosterone. Possible roles in brain development, aging, memory and affect. Ann. N.Y. Acad. Sci. 774 (1995) 111-121
21. Majewska M.D. HPA axis and stimulant dependence: an enigmatic relationship. Psychoneuroendocrinology 27 (2002) 5-12
22. Majewska M.D., and Wilkins J. Low plasma DHEAS levels as markers for refractory cocaine dependence. Neuropsychopharmacology 23 S2 (2000) S46
23. Martin-Soech C., Leenders K.L., Chevalley A.F., Missimer J., Künig G., Magyar S., Mino A., and Schultz W. Reward mechanisms in the brain and their role in dependence: evidence from neurophysiological and neuroimaging studies. Brain Res. Rev. 36 (2001) 139-149
24. Maurice T. Neurosteroids and sigma 1 receptors: biochemical and behavioral relevance. Pharmacopsychiatry 37 suppl. 3 (2004) S171-S182
25. Maurice T. The sigma receptor (σ1) activation is a key step for the reaction of cocaine conditioned place preference by drug priming. Psychopharmacology 175 (2004) 154-162
26. Maurice T., Martin-fardon R., Romieu P., and Matsumoto R.R. Sigma (1) receptor antagonist represents a new strategy against cocaine addition and toxicity. Neurosci. Biobehav. Rev. 26 (2002) 499-527
27. Mellon S.H., and Griffin L.D. Synthesis, regulation and function of neurosteroids. Endocr. Res. 28 (2002) 463
28. Mellon S.H., and Griffin L.D. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13 (2002) 35-43
29. Mendelson J.H., Mello N.K., Sholar M.B., Siegel A.J., Mutschler N., and Halpern J. Temporal concordance of cocaine effects on mood states and neuroendocrine hormones. Psychoneuroendocrinology 27 (2002) 71-82
30. Moldow R.L., and Fischman A.J. Cocaine induced secretion of ACTH beta-endorphin and corticosterone. Peptides 8 (1987) 819-822
31. Murray H.E., and Gillies G.E. Differential effects of neuroactive steroids on somatostatin and dopamine secretion from primary hypothalamic cell cultures. J. Neuroendocrinol. 9 (1997) 287-295
32. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25 (2004) 210-218
33. O'Brien C.P., Childress A.R., Ehrman R., and Robbins S.J. Conditioning factors in drug abuse: can they explain compulsion?. J. Psychopharmacol. 12 (1998) 15-22
34. Piazza P.V., and Le Moal M. The role of stress in drug self administration. Trends Pharmacol. Sci. 19 (1998) 67-74
35. Piazza P.V., Moccari S., Deminiere J.N., Le Moal M., Mormede P., and Simon H. Corticosterone levels determine individual vulnerability to amphetamine self administration. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2088-2092
36. Reddy D.S., and Kukarni S.K. Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice. Eur. J. Pharmacol. 337 (1997) 19-25
37. Reeves R., Thruchelvam M., and Cory-Slechta D.A. Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists. Brain Res. 1008 (2004) 155-167
38. Robel P., and Baulieu E.E. Neurosteroids: biosynthesis and function. Trends Endocrinol. Metab. 5 (1994) 1-8
39. 1 receptor-related neuroactive steroids modulate cocaine-induced reward. J. Neurosci. 23 (2003) 3572-3576
40. 1 receptor (σ1) activation is a key step for the reactivation of cocaine conditioned place preference by drug priming. Psychopharmacology 175 (2004) 154-162
41. Rupprecht R., and Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 22 (1999) 410-416
42. Saphier D., Welch J.E., Farrar G.E., and Goeders N.E. Effects of introcerebroventricular and intrahypothalamic cocaine administration on adrenocortical secretion. Neuroendocrinology 57 (1993) 54-62
43. Sarnyai Z., Shaham Y., and Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 53 (2001) 209-243
44. Shaham Y., and Stewart J. Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats. Psychopharmacology 114 (1994) 523-527
45. Shoptaw S., Majewska M.D., Wilkins J., Twitchell G., Yang X., and Ling W. Participants receiving dehydroepiandrosterone during treatment for cocaine dependence show high rates of cocaine use in a placebo-controlled pilot study. Exp. Clin. Psychopharmacol. 12 (2005) 126-135
46. Sobrian S.K., Marr L., and Ressman K. Prenatal cocaine and/or nicotine exposure produces depression and anxiety in aging rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 (2003) 501-518
47. Su T.P., and Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr. Med. Chem. 10 (2003) 2073-2080
48. Sutton M.A., Schmidt Choi K.H., Schad C.A., Whisler K., Simmons D., Karanian D.A., Monteggia I.M., Neve R.I., and Self D.W. Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature 421 (2003) 70-75
49. Ungard J.T., Beekman M., Gasio M., Carter R.B., Dijkstra D., and Witkin J.M. Modification of behavioral effects of drugs in mice by neuroactive steroids. Psychopharmacology 148 (2000) 336-343
50. Vanover K.E., Suruki M., Huber M., Wilent W.B., and Carter R.B. Neuroactive steroids attenuate cocaine-induced sucrose intake in rats, but not cocaine-induced hyperactivity in mice. Psychopharmacology 149 (2000) 269-276
51. Wilkins J., Van Gorp W., Hinken C., Welch S., Wheatley A., Plotkin D., Moore L., Setoda D., Ashoftwch A., and Majewska M.D. Relapse to cocaine use may be predicted in early abstinence by low plasma dehydroepiandrosterone levels. NIDA RES. Monogr. Serv. 174 (1997) 183
52. Wilkins J.N., Majewska M.D., Van Gorp W., Li S.H., Hinken C., Plotkin D., and Setoda D. DHEAS and POMS measures identify cocaine dependence treatment outcome. Psychoneuroendocrinology 30 (2005) 18-28
53. Wu F.S., Gibbs T.T., and Farb D.H. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor. Mol. Pharmacol. 40 (1991) 333-336
54. Xiuhai R., Yukihiro N., Takayoshi M., Taku N., and Toshitaka N. A neuroactive steroid dehydroepiandrosterone sulfate prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Behav. Brain Res. 152 (2004) 243-250
55. Yadid G., Pacak K., Kopin I.J., and Goldstein D.S. Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol. Exp. Ther. 270 (1994) 1158-1165
56. Zangen A., Overstreet D.H., and Yadid G. High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J. Neurochem. 69 (1997) 2477-2483
57. Zangen A., Overstreet D.H., and Yadid G. Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment. Brain Res. 824 (1999) 243-250